|
Sign In to gain access to subscriptions and/or personal tools.
|
Leucodepletion and the interaction of polymorphonuclear cells with endothelium in systemic inflammatory response syndrome
K A Brown
Department of Immunobiology, Guys, Kings and St Thomas Hospital Medical Schools, University College, London
S M Lewis
Department of Immunobiology, Guys, Kings and St Thomas Hospital Medical Schools, University College, London
T A Hill
Department of Immunobiology, Guys, Kings and St Thomas Hospital Medical Schools, University College, London
M G Macey
Department of Haematology, The Royal London Hospital, University College, London
D A McCarthey
Department of Haematology, The Royal London Hospital, University College, London
V A Grant
Department of Microbiology, University College, London
D F Treacher
Intensive Treatment Unit, Guys and St Thomas Hospital NHS Trust, London
The abnormal interaction of polymorphonuclear cells (PMNs) with blood vessel walls is considered to underlie the multiple organ failure of systemic inflammatory response syndrome (SIRS). This consideration is supported by the present finding that PMNs from patients with SIRS are activated, as assessed by an increased distribution of cells bearing CD64, enhanced expression of CD11b and decreased expression of CD62L, and are highly adhesive to endothelial monolayers. Passage of SIRS blood through leucodepletion filters in a laboratory-designed extracorporeal circuit resulted in a marked depletion of PMNs. Of the PMNs that remained in the blood, far fewer cells bound to cultured endothelial cells in comparison with PMNs prior to leucofiltration. We propose that leucofiltration of SIRS blood will limit the number of PMNs available for binding to blood vessel walls and, hence, reduce the pathological manifestations associated with this disorder.
Perfusion, Vol. 16, No. 1 suppl,
75-83 (2001)
DOI: 10.1177/026765910101600i111

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. de Lange, K. Yoshitani, A. D. Proia, G. B. Mackensen, and H. P. Grocott
Perfluorocarbon Administration During Cardiopulmonary Bypass in Rats: An Inflammatory Link to Adverse Outcome?
Anesth. Analg.,
January 1, 2008;
106(1):
24 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yamazaki, R. Aeba, R. Yozu, and K. Kobayashi
Use of Hemoglobin Vesicles During Cardiopulmonary Bypass Priming Prevents Neurocognitive Decline in Rats
Circulation,
July 4, 2006;
114(1_suppl):
I-220 - I-225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. H. Hovels-Gurich, K. Konrad, D. Skorzenski, C. Nacken, R. Minkenberg, B. J. Messmer, and M.-C. Seghaye
Long-Term Neurodevelopmental Outcome and Exercise Capacity After Corrective Surgery for Tetralogy of Fallot or Ventricular Septal Defect in Infancy.
Ann. Thorac. Surg.,
March 1, 2006;
81(3):
958 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Sato, D. T. Laskowitz, E. R. Bennett, M. F. Newman, D. S. Warner, and H. P. Grocott
Differential Cerebral Gene Expression During Cardiopulmonary Bypass in the Rat: Evidence for Apoptosis?
Anesth. Analg.,
June 1, 2002;
94(6):
1389 - 1394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Gourlay, P. K Ballaux, E. R. Draper, and K. M Taylor
Early experience with a new technique and technology designed for the study of pulsatile cardiopulmonary bypass in the rat
Perfusion,
May 1, 2002;
17(3):
191 - 198.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Dalton, J. S. Krauss, D. G. Falls III, and G. K. Fuller
Granulocytic Fragments in Sepsis
Ann. Clin. Lab. Sci.,
October 1, 2001;
31(4):
365 - 368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D F Treacher, M Sabbato, K A Brown, and V Gant
The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass
Perfusion,
January 1, 2001;
16(1_suppl):
67 - 73.
[Abstract]
[PDF]
|
 |
|
|
|